(Q42163736)

English

Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis

scientific article published on March 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

1 reference

based on heuristic

inferred from title

author name string

Robert Anolik

1

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Mometasone Furoate Nasal Spray With Loratadine Study Group

2

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

publication date

1 March 2008

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Annals of Allergy, Asthma & Immunology

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

100

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

264-271

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Requirements for medications commonly used in the treatment of allergic rhinitis. European Academy of Allergy and Clinical Immunology (EAACI), Allergic Rhinitis and its Impact on Asthma (ARIA).

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960452-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960452-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960452-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Allergic rhinitis and its impact on asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960452-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960452-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Desloratadine reduces nasal congestion in patients with intermittent allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960452-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Fexofenadine reduces nasal congestion in perennial allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960452-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of levocetirizine as add-on therapy to fluticasone in seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960452-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960452-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A placebo- and active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with mometasone furoate aqueous nasal spray

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960452-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose ranging study of mometasone furoate (Nasonex) in seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960452-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Relief of cough and nasal symptoms associated with allergic rhinitis by mometasone furoate nasal spray

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960452-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Mometasone furoate improves congestion in patients with moderate-to-severe seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960452-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. 194-079 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960452-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-blind placebo-controlled study of loratadine, mequitazine, and placebo in the symptomatic treatment of seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960452-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Is the usage of intranasal glucocorticosteroids alone in allergic rhinitis sufficient?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960452-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of intranasal corticosteroids and antihistamines in allergic rhinitis: a review of randomized, controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960452-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of beclomethasone dipropionate aqueous nasal spray, astemizole, and the combination in the prophylactic treatment of ragweed pollen-induced rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960452-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Intranasal corticosteroids for allergic rhinitis: superior relief?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960452-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular mechanisms of corticosteroids in allergic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960452-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of inhaled corticosteroids. New developments

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960452-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of topical corticosteroids on seasonally induced increases in nasal mast cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960452-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Nasal mucosal mast cells and histamine in hay fever. Effect of topical glucocorticoid treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960452-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Activation of guinea pig lymphocytes and mast cells by grain-dust extract

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960452-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiallergic activity of H1-receptor antagonists assessed by nasal challenge

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960452-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Suppressive effect of loratadine on allergen-induced histamine release in the nose

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960452-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1081-1206(10)60452-8

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42163736&oldid=1935047246"